Total extracts prepared from strains expressing Prp43 WT (A) or the R159A (B) and F357A (C) mutants were sedimented through 10-50% sucrose gradients. The ribosome profiles corresponding to the absorbance at 254 nm as a function of collection time (fractions) is shown in the upper panel. The 40S, 60S, 80S and polysome peaks are annotated. RNAs extracted from fractions 1 to 20 were analysed by Northern blot and the snoRNAs snR50, snR41, snR39 and U3, as well as the 35S, 33S/32S and 27S pre-rRNAs were detected using specific radiolabelled oligonucleotide probes. Their sedimentation profiles are presented in the lower panel. As a control to normalize exposure times, RNAs extracted form a sample of each total extract loaded on the gradients were analysed in parallel (T). (D) PhosphorImager quantifications of the pool of free snoRNAs (snoRNAs present in fractions 1-5) relatively to the signal corresponding to the snoRNAs in the input sample (T).
Supplementary materials and methods

RNA binding assays
The fluorescently 5' IRD800-labeled RNA (5'-IRD800-GACGGGCUGUUGGUGAUGGAC) was ordered to IDT. The ssRNA was diluted to 0.5 nM into binding buffer (PBS, 2 mM MgCl2, 6% glycerol, 0.5 mM DTT, 0.1 mM EDTA, 5 μg/ml of E.coli tRNA, 50 μg of BSA). Binding reactions consisted of 10 μl of ssRNA at 0.5 nM and 5 μl of proteins (final concentration from 0.5 to 3000 nM). Binding reactions were incubated for 15 min at 20°C and then directly applied to filters containing the two membranes under vacuum. Before and after application of the binding reactions, 200 μl of binding buffer was used to equilibrate and rinse the system. Binding was quantified using Odyssey apparatus (Li-COR) and Image Lite program (Li-COR). The intensity was corrected for background and fit for Kd using Gnuplot (http://www.gnuplot.info).
Helicase assays
Wild-type or mutant Prp43 proteins (10 nM) and Pfa1 (25 nM) were pre-incubated on ice with 1 nM of the 3′-5′ helicase substrate in a buffer containing 25 mM HEPES-KOH (pH 8.0), 2.5 mM Mg(CH 3 COO) 2 , 100 mM KCl, 0.2 mM DTT, 100 μg/ml BSA (Sigma). ATP was added at a concentration of 1 mM and the reactions were incubated at 30°C for the indicated times. At each time point, reactions were stopped with a solution containing 1 mg/ml proteinase K, 1.25% SDS, 10 mM Tris-HCl, 0.06% bromophenol blue, 0.06% xylene cyanol and 30% glycerol and a 100-fold excess of the trap oligonucleotide. Reaction products were separated on 8% polyacrylamide/1X TBE gels. Gels were dried and quantified using PhosphorImager screens
Yeast strains
The yeast strains used in Supplementary Figure 4 are derived from the BMA64 background (ura3-1, trp1-Δ2, ade2-1, leu2-3,112, his3-11,15, can1-100) . The wild-type or R159A, E216A or F357A mutant PRP43 ORFs were cloned into plasmid pHA113 (centromeric vector with TRP1 auxotrophy marker) under the control of the GAR1 promoter and upstream of a sequence encoding the ZZ tag (ZZ domains from protein A of S. aureus). These plasmids were transformed into a GAL::PRP43 strain, expressing endogenous PRP43 under the control of the conditional galactose promoter.
The yeast strains used in Supplementary Figure 5 are haploid BMA64 cells in which full deletion of the chromosomal PRP43 gene is rescued by pHA113 plasmids expressing wild-type PRP43 or the R159A and F357A mutants.
Yeast strains used in Supplementary figures 5 and 6 are derived from the BMA64 background (ura3-1, trp1-Δ2, ade2-1, leu2-3,112, his3-11,15, can1-100). Wild-type or mutant PRP43 ORFs were cloned into plasmid pHA113 (centromeric vector with TRP1 auxotrophy marker) under the control of the GAR1 promoter and upstream of a sequence encoding the ZZ tag (ZZ domains from protein A of S. aureus). These plasmids were transformed into a diploid strain in which one allele of PRP43 was deleted by replacement by the G418 resistance maker (kan R MX6) according to (Longtine et al., 1998, Yeast) . After sporulation and tetrad dissections, haploid clones were selected in which deletion of the chromosomal PRP43 allele is rescued by the plasmid-borne copies of the WT or mutant PRP43 genes. The resulting strains were propagated on a rich medium supplemented with glucose (YPD).
Soluble protein extracts and Western blot experiments
Cell pellets corresponding to 50 ml of yeast cultures were resuspended with 600 µl A200 KCl Buffer (20 mM Tris-HCl pH 8.0, 5 mM MgAc, 200 mM KCl, 0.2% Triton X-100, 1 mM DTT) supplemented with 1X complete EDTA-free protease inhibitor cocktail (ROCHE) and 0.1 U/µl RNasin (Promega). Cells were broken by vortexing in the presence of glass beads. Extracts were clarified by two consecutive centrifugations at 13 000 rpm, 5 min, 4°C, the soluble fractions were collected and calibrated using Nanodrop. Equal amounts of total proteins were mixed with SDS loading buffer, separated on SDS-10% polyacrylamide gels and transferred to Amersham Hybond-C Extra membranes (GE Healthcare). Prp43 and Nhp2 were detected using polyclonal anti-Prp43 and anti-Nhp2 antibodies, respectively, both diluted to 1:3000 in a buffer containing [1X PBS, 0.5% TWEEN 20, 5% powder milk] and HRP-conjugated goat anti-Rabbit secondary antibodies (Promega).
Sedimentations on sucrose gradients
Yeast cell pellets were broken with glass beads in buffer K (20 mM Tris-Cl pH 7.4, 50 mM KCl, 10 mM MgCl2, 50 µg/ml cycloheximide, 1 mM dithiothreitol, 1X Roche Complete EDTA-free protease inhibitor cocktail, 0.1 U./µl Promega RNasin). Extracts were clarified by centrifugation, calibrated, loaded on 10% to 50% sucrose gradients and centrifuged at 39 000 rpm for 150 min on a Beckman-Coulter Optima L-100 XP ultracentrifuge using a SW41 rotor. Fractions were collected using a Foxy Jr. gradient collector (Teledyne Isco).
